post-2010

Posted on: 20 August 2015

(1) On request from clinicians, Cyclotek validates the GMP production of FET;
(2) Cyclotek participates in clinical trial of PET tracer MEL050, for CRC for Biomedical Imaging Development. The purpose of this study is to investigate the safety and potential effectiveness of MEL050 for metastatic melanoma.